Небилонг Drug photo

The description is actual on 11.07.2016

  • Latin name: Nebilong
  • ATH code: C07AB12
  • Active ingredient: Nebivolol (Nebivolol)
  • Producer: MICRO LABS Limited (India)


Nebivolola hydrochloride, beta cyclodextrin, croscarmellose sodium, lactose, magnesium stearate, sodium sulfate dioctyl, silicon dioxide, microcrystallic cellulose, talc, povidone.

Release form

Tablets 2,5; 5 and 10 mg in the blister in cardboard packaging No. 15, 50, 105.

Pharmacological action

Antiarrhytmic, anti-anginal, hypotensive.

Pharmacodynamics and pharmacokinetics


Drug is cardioselective beta1-adrenoblocker, having vazodilatiruyushchy effect. Blocks beta1-adrenoceptors, transforms process of development of the endothelial running-down factor. Decrease in the ABP is caused by reduction of OPSS, cordial emission, OTsK, braking of process of formation of a renin, lowering of sensitivity of baroreceptors.

As a rule, the hypotensive effect is shown in 1–2 weeks, and its stabilization — for a month. Nebilong lowers ChSS at loading and at rest, reduces oxygen requirement of a cardiac muscle, improves diastolic filling, reduces the weight and an index of mass of a myocardium, exerts beneficial effect on a day-night rhythm of the ABP. Does not influence a lipidic exchange.


Drug is quickly absorbed from a gastrointestinal tract. High communication with blood proteins (98%). Gets through GEB. It is metabolized in a liver. Are allocated in the form of glucuronides with urine and a stake.

Indications to use

Arterial hypertension, prevention of attacks of an angina of exertion, ischemic heart disease, in the combined treatment of HSN.


High sensitivity to drug, bronchial asthma, diseases of a liver, HSN in a decompensation stage, a pheochromocytoma not treated, angiospastic stenocardia, arterial hypotension, depressions, cardiogenic shock, bradycardia, a myasthenia, age till 18 flyings.

Side effects

Feeling of fatigue, dizziness, headache, paresthesias, depression, drowsiness, decrease in concentration of attention, sleeplessness, hallucinations, nausea, xerostomia, orthostatic hypotension, diarrhea/lock, hypostases, asthma, bradycardia, local allergic reactions, cardialgia, arrhythmias, rhinitis, bronchospasm, hyperhidrosis, photodermatosis.

Nebilong, application instruction (Way and dosage)

To accept inside in the morning adult in a dose of 2,5-5 mg a day. According to indications it is possible to increase a dose to 10 mg a day. To patients of advanced age the initial dose makes 2,5 mg a day which according to indications it is possible to increase to 5 mg.


It is shown by arterial hypotension, bradycardia, acute heart failure, a bronchospasm.


At a concomitant use of drug with cardiac glycosides of strengthening of influence on delay of atrioventricular conductivity it is not revealed. The concomitant use of Nebilonga with HP for the general anesthesia increases probability of development of arterial hypotension and suppresses reflex tachycardia.

At a concomitant use of drug with Cimetidinum concentration of Nebilonga in blood increases. The medicamentous means suppressing the return serotonin reuptake slow down a metabolism of Nebilonga. Sympathomimetics reduce activity of Cimetidinum. Barbiturates, tricyclic antidepressants can strengthen hypotensive action.

Terms of sale

Prescription issue.

Storage conditions

At a temperature no more than 25 °C.

Period of validity

24 months.

Pregnancy and lactation

Administration of drug during pregnancy is made only according to strict indications because of high risk of development in newborns of arterial hypotension, bradycardia, paralysis of breath, a hypoglycemia. Reception of Nebilonga should be stopped in 2-3 days prior to the expected term of childbirth. If it is impossible or childbirth came strict control of a condition of the newborn child within the first three days of life is prematurely necessary.

Analogs of Nebilonga

Bivotenz, Binelol, Nebivator, Nebivolol, Nebikor, Adifarm, Nebilet, Nevotenz, AUDE-not B.


  • Nebilong 5 mg No. 50 tabletkimicro Labs
  • Nebilong 10 mg No. 30 tabletkimicro Labs
  • Nebilong 5 mg No. 30 tabletkimicro Labs
  • Nebilong mg AM 5 +5mg No. 30 tabletkimicro Labs
  • Nebilong N 12,5mg +5mg No. 30 tabletkimicro Labs
to show still


  • Nebilong tablets 5 of mg No. 30 Micro Labs (India)


  • Nebilong tab. of 5 mg No. 30
Section: Cardiological
in more detail

Education: Graduated from Sverdlovsk medical school (1968 - 1971) as "Paramedic". Graduated from the Donetsk medical institute (1975 - 1981) as "An epidemiologist, a hygienist". Passed postgraduate study in the Central scientific research institute of epidemiology Moscow (1986 - 1989). An academic degree – the candidate of medical sciences (degree is awarded in 1989, protection – the Central scientific research institute of epidemiology Moscow). Numerous advanced training courses are studied in epidemiology and infectious diseases.

Experience: Work as the manager of department of disinfection and sterilization of 1981 - 1992. Work as the manager of department of especially dangerous infections of 1992 - 2010. Teaching activity at Medical institute 2010 - 2013.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before use of medicine of Nebilong surely consult with the attending physician.